Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION FOR PREVENTING OR TREATING CANCER
Document Type and Number:
WIPO Patent Application WO/2021/080363
Kind Code:
A1
Abstract:
A pharmaceutical composition according to the present invention can be used to effectively treat and prevent the recurrence of pediatric cancers, preferably, pediatric thyroid cancer, which develop in cancer patients, especially those under the age of twenty. It is expected that a more effective cancer treatment can be provided to young cancer patients by presenting an anticancer drug customized to genetic information on the basis of the genetic information.

Inventors:
CHEONG JAE HO (KR)
PARK KI CHEONG (KR)
KIM SEOK MO (KR)
Application Number:
PCT/KR2020/014546
Publication Date:
April 29, 2021
Filing Date:
October 23, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV YONSEI IACF (KR)
International Classes:
A61K31/145; A61P35/00
Foreign References:
KR20150118159A2015-10-21
KR20170124641A2017-11-10
JP2002500180A2002-01-08
KR20190056758A2019-05-27
Other References:
YANG JIAO, HANNAFON BETHANY N, DING WEI-QUN: "Anti-Cancer Agents in Medicinal Chemistry Disulfiram's Anticancer Activity: Evidence and Mechanisms", ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, vol. 16, 1 January 2016 (2016-01-01), pages 1379 - 1384, XP055660417, DOI: 10.2174/18715206156661605040950
HAN DAN, WU GANG, CHANG CHAN, ZHU FANG, XIAO YIN, LI QIUHUI, ZHANG TAO, ZHANG LILING: "Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway", ONCOTARGET, IMPACT JOURNALS LLC, UNITED STATES, 1 December 2015 (2015-12-01), United States, pages 40907 - 40919, XP055804163, Retrieved from the Internet DOI: 10.18632/oncotarget.5723
Attorney, Agent or Firm:
LEE, Jae Young (KR)
Download PDF: